Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level

Background: Inflammasome complex such as nucleotide oligomerization domain-like receptor family protein 3 (NLRP3) acts as a trigger initiating inflammatory responses and could lead to endothelial dysfunction in diabetic patients and glycemic control could affect the mitochondrial stress through NLRP...

Full description

Saved in:
Bibliographic Details
Main Authors: Refif Sabih Al-Shawk, Zainab Fadhel Ashoor, Wasan Abdul-elah Bakir, Intisar Manfi Ahmed
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Medical Journal of Babylon
Subjects:
Online Access:https://doi.org/10.4103/MJBL.MJBL_799_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841525562333462528
author Refif Sabih Al-Shawk
Zainab Fadhel Ashoor
Wasan Abdul-elah Bakir
Intisar Manfi Ahmed
author_facet Refif Sabih Al-Shawk
Zainab Fadhel Ashoor
Wasan Abdul-elah Bakir
Intisar Manfi Ahmed
author_sort Refif Sabih Al-Shawk
collection DOAJ
description Background: Inflammasome complex such as nucleotide oligomerization domain-like receptor family protein 3 (NLRP3) acts as a trigger initiating inflammatory responses and could lead to endothelial dysfunction in diabetic patients and glycemic control could affect the mitochondrial stress through NLRP3 inflammasome level. Objectives: This study was conducted to ensure that type 2 diabetes mellitus (T2DM) glycemic control could affect mitochondrial stress through NLRP3 inflammasome level leading to an aberrant immune response. Materials and Methods: A case–control study was conducted on 90 Iraqi subjects, 60 of them were T2DM who were subgrouped into 30 patients with good glycemic control (HbA1c ≤ 7%) and the second group with 30 patients with poor (bad) glycemic control (HbA1c > 7%). Also, 30 healthy control subjects were enrolled in this study. HbA1c, fasting blood glucose (FBG), and serum levels of NLRP3 and interferon (IFN)-γ were quantitatively determined by means of a sandwich enzyme-linked immunosorbent assay (ELISA) test. Results: Results of this study showed a significant increase in serum levels of NLRP3 and IFN-γ in the poor glycemic control group of patients as compared to control subjects (P ≤ 0.05), while this difference was not significant when comparing the good glycemic control group of patients with control subjects. There is a significant positive correlation of serum NLRP3 with only IFN-γ (P ≤ 0.05) in both good and poor glycemic control and healthy controls. Conclusion: An increased level of NLRP3 was observed in poor glycemic control T2DM and correlated with IFN-γ, suggesting hyperglycemia’s effect on this inflammasome pathway that could be associated with aberrant cytokine induction, a key inducer of diabetic complications.
format Article
id doaj-art-a20e3bc2bfa04be4b6e86ff03f98e409
institution Kabale University
issn 1812-156X
2312-6760
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Medical Journal of Babylon
spelling doaj-art-a20e3bc2bfa04be4b6e86ff03f98e4092025-01-17T10:54:56ZengWolters Kluwer Medknow PublicationsMedical Journal of Babylon1812-156X2312-67602024-12-0121497097410.4103/MJBL.MJBL_799_23Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome LevelRefif Sabih Al-ShawkZainab Fadhel AshoorWasan Abdul-elah BakirIntisar Manfi AhmedBackground: Inflammasome complex such as nucleotide oligomerization domain-like receptor family protein 3 (NLRP3) acts as a trigger initiating inflammatory responses and could lead to endothelial dysfunction in diabetic patients and glycemic control could affect the mitochondrial stress through NLRP3 inflammasome level. Objectives: This study was conducted to ensure that type 2 diabetes mellitus (T2DM) glycemic control could affect mitochondrial stress through NLRP3 inflammasome level leading to an aberrant immune response. Materials and Methods: A case–control study was conducted on 90 Iraqi subjects, 60 of them were T2DM who were subgrouped into 30 patients with good glycemic control (HbA1c ≤ 7%) and the second group with 30 patients with poor (bad) glycemic control (HbA1c > 7%). Also, 30 healthy control subjects were enrolled in this study. HbA1c, fasting blood glucose (FBG), and serum levels of NLRP3 and interferon (IFN)-γ were quantitatively determined by means of a sandwich enzyme-linked immunosorbent assay (ELISA) test. Results: Results of this study showed a significant increase in serum levels of NLRP3 and IFN-γ in the poor glycemic control group of patients as compared to control subjects (P ≤ 0.05), while this difference was not significant when comparing the good glycemic control group of patients with control subjects. There is a significant positive correlation of serum NLRP3 with only IFN-γ (P ≤ 0.05) in both good and poor glycemic control and healthy controls. Conclusion: An increased level of NLRP3 was observed in poor glycemic control T2DM and correlated with IFN-γ, suggesting hyperglycemia’s effect on this inflammasome pathway that could be associated with aberrant cytokine induction, a key inducer of diabetic complications.https://doi.org/10.4103/MJBL.MJBL_799_23glycemic controlifn-γinflammasomenlrp3type 2 diabetes mellitus
spellingShingle Refif Sabih Al-Shawk
Zainab Fadhel Ashoor
Wasan Abdul-elah Bakir
Intisar Manfi Ahmed
Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level
Medical Journal of Babylon
glycemic control
ifn-γ
inflammasome
nlrp3
type 2 diabetes mellitus
title Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level
title_full Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level
title_fullStr Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level
title_full_unstemmed Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level
title_short Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level
title_sort glycemic control in type 2 diabetes mellitus patients could affect nlrp3 inflammasome level
topic glycemic control
ifn-γ
inflammasome
nlrp3
type 2 diabetes mellitus
url https://doi.org/10.4103/MJBL.MJBL_799_23
work_keys_str_mv AT refifsabihalshawk glycemiccontrolintype2diabetesmellituspatientscouldaffectnlrp3inflammasomelevel
AT zainabfadhelashoor glycemiccontrolintype2diabetesmellituspatientscouldaffectnlrp3inflammasomelevel
AT wasanabdulelahbakir glycemiccontrolintype2diabetesmellituspatientscouldaffectnlrp3inflammasomelevel
AT intisarmanfiahmed glycemiccontrolintype2diabetesmellituspatientscouldaffectnlrp3inflammasomelevel